Point-of-care microfluidic devices for pathogen detection
The rapid diagnosis of pathogens is crucial in the early stages of treatment of diseases
where the choice of the correct drug can be critical. Although conventional cell culture-based …
where the choice of the correct drug can be critical. Although conventional cell culture-based …
Pathogenic mechanisms in HBV-and HCV-associated hepatocellular carcinoma
A Arzumanyan, HM Reis, MA Feitelson - Nature Reviews Cancer, 2013 - nature.com
Hepatocellular carcinoma (HCC) is a highly lethal cancer, with increasing worldwide
incidence, that is mainly associated with chronic hepatitis B virus (HBV) and/or hepatitis C …
incidence, that is mainly associated with chronic hepatitis B virus (HBV) and/or hepatitis C …
[PDF][PDF] Long‐term entecavir treatment reduces hepatocellular carcinoma incidence in patients with hepatitis B virus infection
Chronic hepatitis B virus (HBV) infection leads to cirrhosis and hepatocellular carcinoma
(HCC). Antiviral agents are thought to reduce HCC development, but agents such as …
(HCC). Antiviral agents are thought to reduce HCC development, but agents such as …
[HTML][HTML] Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents
This report updates and combines earlier versions of guidelines for the prevention and
treatment of opportunistic infections (OIs) in HIV-infected adults (ie, persons aged> 18 years) …
treatment of opportunistic infections (OIs) in HIV-infected adults (ie, persons aged> 18 years) …
Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures
D Lavanchy - Journal of viral hepatitis, 2004 - Wiley Online Library
Hepatitis B virus (HBV) infection is a serious global health problem, with 2 billion people
infected worldwide, and 350 million suffering from chronic HBV infection. The 10th leading …
infected worldwide, and 350 million suffering from chronic HBV infection. The 10th leading …
Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level
ContextSerum hepatitis B virus (HBV) DNA level is a marker of viral replication and efficacy
of antiviral treatment in individuals with chronic hepatitis B. ObjectiveTo evaluate the …
of antiviral treatment in individuals with chronic hepatitis B. ObjectiveTo evaluate the …
[PDF][PDF] Chronic hepatitis B
ASF Lok, BJ McMahon - Hepatology, 2007 - Wiley Online Library
These guidelines have been written to assist physicians and other health care providers in
the recognition, diagnosis, and management of patients chronically infected with the …
the recognition, diagnosis, and management of patients chronically infected with the …
Risk estimation for hepatocellular carcinoma in chronic hepatitis B (REACH-B): development and validation of a predictive score
Background Therapy for chronic hepatitis B reduces the risk of progressing to hepatocellular
carcinoma (HCC); however, there is no suitable and accurate means to assess risk. This …
carcinoma (HCC); however, there is no suitable and accurate means to assess risk. This …
Type 1/Type 2 immunity in infectious diseases
B Spellberg, JE Edwards Jr - Clinical Infectious Diseases, 2001 - academic.oup.com
Abstract T helper type 1 (Th1) lymphocytes secrete secrete interleukin (IL)-2, interferon-γ,
and lymphotoxin-α and stimulate type 1 immunity, which is characterized by intense …
and lymphotoxin-α and stimulate type 1 immunity, which is characterized by intense …
Predicting cirrhosis risk based on the level of circulating hepatitis B viral load
Background & Aims: Cirrhosis develops as a result of hepatic inflammation and subsequent
fibrosis in chronic hepatitis B infection. We report on the relationship between hepatitis B …
fibrosis in chronic hepatitis B infection. We report on the relationship between hepatitis B …